Skip to main content
Elsevier

Lipid-Based Nanocarriers for Drug Delivery and Diagnosis

  • 1st Edition - June 7, 2017
  • Latest edition
  • Authors: Muhammad Raza Shah, Muhammad Imran, Shafi Ullah
  • Language: English

Lipid-Based Nanocarriers for Drug Delivery and Diagnosis explores the present state of widely used lipid-based nanoparticulate delivery systems, such as solid lipid nanoparti… Read more

Description

Lipid-Based Nanocarriers for Drug Delivery and Diagnosis explores the present state of widely used lipid-based nanoparticulate delivery systems, such as solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), nanoliposomes, micelles, nanoemulsions, nanosuspensions and lipid nanotubes. The various types of lipids that can be exploited for drug delivery and their chemical composition and physicochemical characteristics are reviewed in detail, along with their characterization aspects and effects of their dimensions on drug delivery systems behavior in-vitro and in-vivo. The book covers the effective utilization of these lipids based systems for controlled and targeted delivery of potential drugs/genes for enhanced clinical efficacy.

Key features

  • Provides the present state of widely used lipid-based nanoparticulate delivery systems
  • Explores how lipid-based nanocarriers improve drug delivery safety
  • Describes the nanoformulation design and the preparation methods of lipid-based nanocarriers

Readership

Researchers and bioengineers working in the areas of nanomedicine and drug delivery

Table of contents

1. Solid Lipid Nanoparticles2. Nanostructured Lipid Carriers3. Nanostructured Lipid Carriers4. Nanoemulsions5. Nanosuspensions6. Lipid Nanotubes7. Ultrasound-Responsive Nanosystems8. Liposomes for Targeted Drug Delivery in Cancer Therapy9. Lipid-Based Nanocarriers for Cancer Gene Therapy10. pH and Temperature Responsive Nanosystems11. Niosomal Drug Delivery

Product details

  • Edition: 1
  • Latest edition
  • Published: June 7, 2017
  • Language: English

About the authors

MS

Muhammad Raza Shah

Prof. Muhammad Raza Shah is a professor and Director of the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan. He holds four US patents. Dr. Shah has received numerous awards, including the Khwarizmi International Award from the Ministry of Science, Research and Technology, Iran (2023). He has also been honored with the Civil Award Tamgha-i-Imtiaz (2015), Dr. Raziuddin Prize (2015), Prof. Atta-ur-Rahman Gold Medal by the Pakistan Academy of Sciences, Avicenna Science & Innovation Award (2015) by Brain Trust UK, and the Abdus Salam Award in Chemistry (2006). He was named TWAS Young Affiliate in 2010 by The World Academy of Sciences. Prof. Shah is a Fellow of the International Union of Pure and Applied Chemistry, the Chemical Society of Pakistan, the Islamic World Academy of Sciences, and the Royal College of Physicians (Edinburgh). Dr. Shah has conducted 29 Phase-I (BE and PK) studies, 04 Phase-II Randomized Clinical Trial as PI and lead the Phase-I RCT of Sinopharm COVID-19 vaccine and Phase-III RCT of COVID-19 booster vaccine as country PI.
Affiliations and expertise
Professor, International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University, Karachi, Pakistan

MI

Muhammad Imran

Muhammad Imran is a graduate student and based at the International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University of Karachi, Pakistan.
Affiliations and expertise
International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry, University of Karachi, Pakistan

SU

Shafi Ullah

Shafi Ullah is a graduate student and based at the International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University of Karachi, Pakistan.
Affiliations and expertise
International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry, University of Karachi, Pakistan

View book on ScienceDirect

Read Lipid-Based Nanocarriers for Drug Delivery and Diagnosis on ScienceDirect